Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

957
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
957
Inhaled Medications01:23

Inhaled Medications

912
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
912
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

848
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
848
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

875
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
875
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

5.4K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts Association Tunisienne de Médecine Néonatale (ATMN).

La Tunisie medicale·2026
Same author

Digital perinatal mental health screening and psychosocial assessment using iCOPE: experiences and insights from healthcare providers.

Midwifery·2026
Same author

Shared Decision-Making Supported by Outcome Information During Discharge Planning of Patients Hospitalized With Stroke.

Neurology. Clinical practice·2025
Same author

Implementation of a patient decision aid for discharge planning of hospitalized patients with stroke: aprocess evaluation using a mixed-methods approach.

Patient education and counseling·2025
Same author

Technical feasibility of automated blur detection in digital mammography using convolutional neural network.

European radiology experimental·2024
Same author

Prevalence of Medical Mistrust and Its Impact on Patient Satisfaction in Pediatric Caregivers.

Journal of racial and ethnic health disparities·2024

Related Experiment Video

Updated: Mar 1, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.6K

A Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects.

D Rüppel1, R Dahmen1, A Boss2

  • 1Sanofi-Aventis Deutschland GmbH, R&D Frankfurt, Germany.

CPT: Pharmacometrics & Systems Pharmacology
|June 2, 2017
PubMed
Summary

Technosphere insulin (TI), an inhaled rapid-acting insulin, was compared to regular human insulin (RHI). A pharmacokinetic-GIR model estimated TI requires a 5-fold higher dose than RHI for equivalent glucose control.

More Related Videos

Intratracheal Administration of Dry Powder Formulation in Mice
07:55

Intratracheal Administration of Dry Powder Formulation in Mice

Published on: July 25, 2020

12.4K
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.9K

Related Experiment Videos

Last Updated: Mar 1, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.6K
Intratracheal Administration of Dry Powder Formulation in Mice
07:55

Intratracheal Administration of Dry Powder Formulation in Mice

Published on: July 25, 2020

12.4K
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.9K

Area of Science:

  • Pharmacology
  • Endocrinology
  • Pharmacokinetics

Background:

  • Technosphere insulin (TI) offers a novel approach to prandial glucose control due to its rapid onset.
  • Comparing TI efficacy to traditional insulins is crucial for clinical application.

Purpose of the Study:

  • To compare the glucose-lowering effects of TI and regular human insulin (RHI) in healthy volunteers.
  • To develop a pharmacokinetic-GIR model to establish a dose-response relationship for TI and RHI.

Main Methods:

  • A euglycemic glucose clamp study was conducted in healthy volunteers.
  • A pharmacokinetic-GIR model was developed to simulate glucose infusion rate (GIR) over 20 hours.
  • Dose-response models were generated from simulated GIR profiles.

Main Results:

  • Direct clinical data did not allow for a complete dose-response relationship due to limited recording time and tested doses.
  • The developed model simulated GIR for extended periods and higher doses.
  • The model indicated an ED50 for TI that is 5-fold higher than for RHI.

Conclusions:

  • A 5-fold higher dose of TI compared to RHI is estimated for equivalent glucose-lowering effect.
  • This ratio can serve as a conversion factor for determining equivalent insulin doses.
  • The pharmacokinetic-GIR model successfully simulated dose-response relationships for inhaled insulin therapy.